We further analysed lung cancer patients receiving surgery and chemotherapy separately, and the results showed that the OS (P = 0.006) and PFS (P = 0.004) of lung cancer patients with high syntenin expression were significantly shorter than those with low syntenin expression in 80 surgically treated patients (Fig. 3c and d). This evidence concerns the gene SDCBP and lung cancer.